GLAZER CAPITAL, LLC - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 23 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GLAZER CAPITAL, LLC ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2021$2,374,000
-10.9%
239,510
-11.0%
0.06%
+23.4%
Q3 2021$2,663,000
-6.2%
268,975
-5.3%
0.05%
+6.8%
Q2 2021$2,838,000
-9.0%
284,104
-8.4%
0.04%
-2.2%
Q1 2021$3,120,000310,0000.04%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q1 2022
NameSharesValueWeighting ↓
First Trust Capital Management L.P. 210,000$2,098,0000.31%
Arena Capital Advisors, LLC- CA 225,899$2,257,0000.19%
PERISCOPE CAPITAL INC. 465,285$4,648,0000.15%
Wealthspring Capital LLC 54,647$545,0000.14%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,689$657,0000.08%
Mint Tower Capital Management B.V. 100,000$999,0000.07%
Sage Mountain Advisors LLC 41,340$413,0000.07%
GLAZER CAPITAL, LLC 284,104$2,838,0000.04%
KING STREET CAPITAL MANAGEMENT, L.P. 50,000$500,0000.04%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 30,062$300,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders